Eribulin-induced resolution of high-risk basal cell carcinoma: implications for microtubule-targeting agents in BCC management: a case report

Key Points

• Resolution of high-risk basal cell carcinoma was achieved using eribulin, a microtubule-targeting agent.
• The treatment resulted in significant tumor shrinkage, showcasing eribulin's potential in BCC management.
• Observational analysis provided insights into chemotherapy options for managing challenging cases of basal cell carcinoma.
• Highlights the need for further exploration of microtubule-targeting agents in the treatment of skin cancers.